Flow Cytometry in the Diagnosis of Non-Hodgkin's Lymphoma (NHL)

References

• Grogan TM, Spier CM, Richter LC et al: Immunologic approaches to the classification of non-Hodgkin's lymphomas. In Lymphomas and Leukemias, 3rd ed, Bennett JM, Foon KA (eds). Martinus Nijhoff, 1988, pp 31–148
   Google Scholar
• Little JV, Foucar KM, Horvath A et al: Flow cytometric analysis of lymphoma and lymphoma-like disorders. Semin Diag Pathol 6:37–54, 1989
   PubMed Web of Science ®Google Scholar
• Freedman AS, Nadler LM: Cell surface markers in hemato-logic malignancies. Semin Oncol 14:193–212, 1987
   PubMed Web of Science ®Google Scholar
• Deegan MJ: Membrane antigen analysis in the diagnosis of lymphoid leukemias and lymphomas. Arch Pathol Lab Med 113:606–618, 1989
   PubMed Web of Science ®Google Scholar
• Grogan TM, Fielder K, Rangel C et al: Peripheral T-cell lymphoma: Aggressive disease with heterogeneous immunotypes. Am J Clin Pathol 83:279–288, 1985
   PubMed Web of Science ®Google Scholar
• Spier CM, Grogan TM, Fielder K et al: Immunophenotypes in "well-differentiated" lymphoproliferative disorders, with emphasis on small lymphocyte lymphoma. Hum Pathol 17: 1126–1136, 1986
   PubMed Web of Science ®Google Scholar
• Sundeen JT, Longo DL, Jaffe ES: CD5 expression in B-cell small lymphocytic malignancies. Correlations with clinical presentation and sites of disease. Am J Surg Pathol 16:130–137, 1992
   PubMed Web of Science ®Google Scholar
• Hollema H, Poppema S: Immunophenotypes of malignant lymphoma centroblastic-centrocytic and malignant lymphoma centrocytic: An immunohistologic study indicating a derivation from different stages of B cell differentiation. Hum Pathol 19:1053–1059, 1988
   PubMed Web of Science ®Google Scholar
• Lardelli P, Bookman MA, Sundeen J et al: Lymphocytic lymphoma of intermediate differentiation. Am J Surg Pathol 14: 752–763, 1990
   PubMed Web of Science ®Google Scholar
• Strickler JG, Medeiros Li, Copenhaver CM et al: Intermediate lymphocytic lymphoma: An immunophenotypic study with comparison to small lymphocytic lymphoma and diffuse small cleaved cell lymphoma. Hum Pathol 19:550–554, 1988
   PubMed Web of Science ®Google Scholar
• Miller ML, Fishleder AJ, Tubbs RR: The expression of CD22 (Leu 14) and CD1 1 c (LeuM5) in chronic lymphoproliferative disorders using two-color flow cytometric analysis. Am J Clin Pathol 96:100–108, 1991
   PubMed Web of Science ®Google Scholar
• Foucar K, Chen I-M, Crago S: Organization and operation of a flow cytometric immunophenotyping laboratory. Semin Diag Pathol 6:13–36, 1989
   PubMed Web of Science ®Google Scholar
• Carey JL: Flow cytometric immunoanalysis of leukemia and lymphoma. J Clin Immunoassay 12:21–29, 1989
   Web of Science ®Google Scholar
• Ault KA: Applications in immunology and lymphocyte analysis. In Flow Cytometry and Sorting, 2nd ed, Melamed MR, Lindmo T, Mendelsohn ML (eds). Wiley-Liss, Inc, New York, 1990, pp 685–696
   Google Scholar
• Colvin RB, Preffer FJ: New technologies in cell analysis by flow cytometry. Arch Pathol Lab Med 111:628–632, 1987
   PubMed Web of Science ®Google Scholar
• Coon JS, Landay AL, Weinstein RS: Biology of Disease: Advances in flow cytometry for diagnostic pathology. Lab Invest 57:453–479, 1987
   PubMed Web of Science ®Google Scholar
• Bray RA, Landay AL: Identification and functional characterization of mononuclear cells by flow cytometry. Arch Pathol Lab Med 113:579–590, 1989
   PubMed Web of Science ®Google Scholar
• Traganos F: Flow cytometry: Principles and applications. I. Cancer Invest 2:149–163, 1984
   PubMed Web of Science ®Google Scholar
• Traganos F: Flow cytometry; Principles and applications. II. Cancer Invest 2:239–258, 1984
   PubMed Web of Science ®Google Scholar
• Macartney JC, Camplejohn RS, Morris R et al: DNA flow cytometry of follicular non-Hodgkin's lymphoma. J Clin Pathol 44:215–218, 1991
   PubMed Web of Science ®Google Scholar
• McCarthy RC, Fetterhoff TJ: Issues for quality assurance in clinical flow cytometry. Arch Pathol Lab Med 113:658–666, 1989
   PubMed Web of Science ®Google Scholar
• McCoy JP, Carey JL, Krause JR: Quality control in flow cytometry for diagnostic pathology. 1. Cell surface phenotyping and general laboratory procedures. Am J Clin Pathol 93(Suppl):S27-S37, 1990
   Google Scholar
• Warzynski MJ, Podgurski AE, Boldt DM et al: An automated method to prepare cell suspensions from human biopsy samples for immunophenotyping by flow cytometry. Am J Clin Pathol 93:104–108, 1990
   PubMed Web of Science ®Google Scholar
• Sheibani K, Winberg CD, Van de Velde S et al: Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's Disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases. Am J Pathol 127:27–37, 1987
   PubMed Web of Science ®Google Scholar
• Ratech H, Litwin S: Surface immunoglobulin light chain restriction in B-cell non-Hodgkin's malignant lymphomas. Am J Clin Pathol 91:583–586, 1989
   PubMed Web of Science ®Google Scholar
• Strauchen JA, Mandeli JP: Immunoglobulin expression in B-cell lymphoma. Immunohistochemical study of 345 cases. Am J Clin Pathol 95:692–695, 1991
   PubMed Web of Science ®Google Scholar
• Picker LJ, Weiss LM, Medeiros LJ et al: Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. Am J Pathol 128:181–201, 1987
   PubMed Web of Science ®Google Scholar
• Ngan B, Warnke RA, Cleary ML: Variability of immunoglobulin expression in follicular lymphoma. An immunohistologic and molecular genetic study. Am J Pathol 135:1139–1144, 1989
   PubMed Web of Science ®Google Scholar
• Willman CL, Foucar K, Chen J et al: Dual expression of monocytic and monoclonal B cell markers in B cell-derived lymphomas detected by dual laser flow cytometry. Lab Invest 54:69A, 1986
   Web of Science ®Google Scholar
• Medeiros LJ, Herrington RD, Gonzalez CL et al: My4 anti-body staining of non-Hodgkin's lymphomas. Am J Clin Pathol 95:363–368, 1991
   PubMed Web of Science ®Google Scholar
• Chittal SM, Brousset P, Voigt J-J et al: Large B-cell lymphoma rich in T-cells and simulating Hodgkin's disease. Histopathology 19:211–220, 1991
   PubMed Web of Science ®Google Scholar
• Ramsay AD, Smith WJ, Isaacson PG: T-cell-rich B-cell lymphoma. Am J Surg Pathol 12:433–443, 1988
   PubMed Web of Science ®Google Scholar
• Winberg CD, Sheibani K, Burke JS et al: T-cell-rich lympho-proliferative disorders. Morphologic and immunologic differential diagnoses. Cancer 62:1539–1555, 1988
   PubMed Web of Science ®Google Scholar
• Spier CM, Grogan TM, Lippman SM et al: The aberrancy of immunophenotype and immunoglobulin status as indicators of prognosis in B cell diffuse large cell lymphoma. Am J Pathol 133:118–126, 1988
   PubMed Web of Science ®Google Scholar
• Miller TP, Lippman SM, Spier CM et al: The HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma. J Clin Invest 82:370–372, 1988
   PubMed Web of Science ®Google Scholar
• Grogan TM, Miller TP: New biologic markers in non-Hodgkin's lymphomas. Hem Oncol Cl N Am 5:925–933, 1991
   PubMed Web of Science ®Google Scholar
• Patarroyo M, Makgoba MW: Leucocyte adhesion to cells in immune and inflammatory responses. Lancet 2 1139–1141, Nov 11, 1989
   PubMedGoogle Scholar
• Stamenkovic I, Sgroi D, Aruffo A et al: The B lymphocyte adhesion molecule CD22 interacts with leukocyte common an-tigen CD45R0 on T cells'and a2-6 sialyltransferase, CD75, on B cells. Cell 66:1133–1144, 1991
   PubMed Web of Science ®Google Scholar
• Horst E, RadaszkiQwicz T, Otter AH-d et al: Expression of the leucocyte integrin LFA-1 (CD11a/CD18) and its ligand ICAM-1 (CD54) in lymphoid malignancies is related to lineage deriva-tion and stage of differentiation but not to tumor grade. Leuke-mia 5:848–853, 1991
   PubMed Web of Science ®Google Scholar
• VanRiet I, DeWaele M, Remels L et al: Expression of cytoad-hesion molecules (CD56, CD54, CD18 and CD29) by my-eloma plasma cells. Br J Haematol 79:421–427, 1991
   PubMed Web of Science ®Google Scholar
• Kern WF, Spier CM, Hanneman EH et al: Neural cell adhesion molecule-positive peripheral T-cell lymphoma: A rare variant with a propensity for unusual sites of involvement. Blood 79:2432–2437, 1992
   PubMed Web of Science ®Google Scholar
• Horst E, Meijer CJLM, Radaszkiewicz et al: Adhesion mole-cules in the prognosis of diffuse large-cell lymphoma: Expres-sion of a lymphocyte homing receptor (CD44), LFA-1 (CDI la/ 18), and ICAM-1 (CD54). Leukemia 4:595–599, 1990
   PubMed Web of Science ®Google Scholar
• Medeiros LI, Picker LJ, Gelb AB et al: Numbers of host "helper" T cells and proliferating cells predict survival in dif-fuse small-cell lymphomas. J Clin Oncol 7:1009–1017, 1989
   PubMed Web of Science ®Google Scholar
• Strickler JG, Copenhaver CM, Rojas VA et al: Comparison of "host cell infiltrates" in patients with follicular lymphoma with and without spontaneous regression. Am J Clin Pathol 90: 257–261, 1988
   PubMed Web of Science ®Google Scholar
• Lippman SM, Spier CM, Miller TP et al: Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course. Mod Pathol 3:361–367, 1990
   PubMed Web of Science ®Google Scholar
• Cohen MC, Cohen S: The role of lymphokines in neoplastic disease. Hum Pathol 17:264–270, 1986
   PubMed Web of Science ®Google Scholar
• Peuchmaur M, Emilie D, Crevon M-C et al: Interleukin-2 and interferon-gamma production in follicular lymphomas. Am J Clin Pathol 95:55–62, 1991
   PubMed Web of Science ®Google Scholar
• Foa R, Massaia M, Cardona S et al: Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: A possible regulatory role of TNF in the progression of the disease. Blood 76:393–400, 1990
   PubMed Web of Science ®Google Scholar
• Brenner MK: Interleukin 2 and the treatment of leukemia and lymphoma. Leukemia Lymphoma 5:77–83, 1991
   PubMed Web of Science ®Google Scholar
• Coon JS, Wang Y, Bines SD et al: Multidrug resistance activity in human lymphocytes. Hum Immunol 32:134–140, 1991
   PubMed Web of Science ®Google Scholar
• Pirker R, Wallner J, Geissler K, et al: MDR1 gene expression and treatment outcome in acute myeloid leukemia. J Nati Can-cer lnst 83:708–712, 1991
   PubMed Web of Science ®Google Scholar
• Kuwazuru Y, Yoshimura A, Hanada S et al: Expression of the multidrug transporter, P-glycoprotein, in acute leukemia cells and correlation to clinical drug resistance. Cancer 66:868–873, 1990
   PubMed Web of Science ®Google Scholar
• Musto P, Melillo L, Lombardi G et al: High risk of early resis-tance relapse for leukaemic patients with presence of multi-drug resistance associated P-glycoprotein positive cells in complete remission. Br J Haematol 77:50–53, 1991
   PubMed Web of Science ®Google Scholar